Home > Insider Trading > Filing (0001438133-21-000135)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1438133	Tandem Diabetes Care Inc	TNDM	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1238913	D Kim Blickenstaff	C/O Tandem Diabetes Care, Inc. 11075 Roselle Street San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-08-16	24,240	$109.07	228,150	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-08-17	6,510	$108.09	221,640	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-08-17	19,250	$109.12	202,390	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,892	Direct

Footnotes

The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $109.00 to $109.46. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $108.00 to $108.88. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $109.10 to $109.13. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.